UPDATE: William Blair Downgrades Acer Therapeutics (ACER) to Market Perform, Stock Down -80% Following FDA Complete Response Letter For Edsivo
Tweet Send to a Friend
(Updated - June 25, 2019 9:58 AM EDT)
(Updated to add analyst comment, snippet from company press release published ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(Updated to add analyst comment, snippet from company press release published ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
